Jiri Minarik¹, Luděk Pour, MD^2*, Tomas Jelinek³, Ivan Spicka, CSc^4*, Alexandra Jungova^5*, Jakub Radocha, MD, PhD⁶, Petr Pavlicek^7*, Tomas Pika^8*, Stork Martin^9*, Jan Straub^10*, Vojtech Latal^11*, Dominik Fric^2*, Vladimir Maisnar, MD, PhD^6* and Roman Hajek, MD, PhD¹²

¹Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic
²Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic
³Department of Hematooncology, University Hospital Ostrava, Ostrava, Ostrava-Mesto, Czech Republic
⁴1st Medical Department – Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Prague, Czech Republic
⁵Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic
⁶4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
⁷3rd Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady, Department of Internal Medicine and Hematology, Prague, Czech Republic
⁸Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
⁹Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
¹⁰1st Medical Department – Clinical Department of Haematology, First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic
¹¹University Hospital and Palacky University Olomouc, Olomouc, CZE
¹²University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic

Andrew J. Cowan, MD¹, Luuk Gras^2*, Hiroyuki Takamatsu, MD, PhD^3,4, Linda Koster^5*, Laurien Baaij III^6*, Nada Hamad, MBBS, MSc, BSc⁷, Anita D'Souza, MD⁸, Noel Estrada-Merly, MS^9*, Parameswaran N. Hari, MD, MBBS¹⁰, Wael Saber, MD, MS¹¹, Minako Iida, MD, PhD^12*, Shinichiro Okamoto^13*, Shohei Mizuno, MD, PhD^14*, Koji Kawamura, MD, PhD^15*, Yoshihisa Kodera, MD^16*, Bor-Sheng Ko, M.D. Ph.D.¹⁷, Christopher Liam, MRCP^18*, KIM Wah HO, MBBS, MRCP^19*, A Sim Goh, MD^20*, S Keat Tan^21*, Alaa M. Elhaddad, MD²², Ali Bazarbachi, MD, PhD²³, Brig Qamar Un N Chaudhry, MBBS, FCPS^24*, Rozan Alfar, MBBS^25*, Mohamed Amine Bekadja^26*, Malek Benakli, MD^27*, Cristobal Augusto Frutos Ortiz, MD^28*, Eloisa Riva, MD, MEd²⁹, Sebastian Galeano, MD³⁰, Francisca Bass, MD^31*, Hira Mian, MD³², Arleigh McCurdy, MD³³, Feng-Rong Wang, MD^34*, Meng Lv, MD, PhD³⁵, Daniel Neumann^36*, Mickey Boon Chai Koh, MD, PhD^37*, John Snowden, MD^38*, Stefan Schonland^39*, Donal P McLornan, MD, PhD^40*, Patrick John Hayden, MD⁴¹, Rafael De La Camara, MD⁴², Raffaella Greco, MD^43*, Fabio Ciceri, MD^44*, Mette D. Hazenberg, MD, PhD^45*, Anna Sureda Balari, MD, PhD⁴⁶, Damiano Rondelli, MD^47*, Hildegard T. Greinix, MD⁴⁸, Mahmoud Aljurf^49*, Yoshiko Atsuta^50*, Dietger W. Niederwieser, MD⁵¹ and Laurent Garderet^52*

¹Fred Hutchinson Cancer Center, Seattle, WA
²EBMT, Leiden, Netherlands
³Department of Hematology, Kanazawa University, Kanazawa, Japan
⁴Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
⁵EBMT Leiden Study Unit, Leiden, Netherlands
⁶EBMT Leiden Study Unit, Leiden, the Netherlands;, Leiden, Netherlands
⁷St Vincent's Hospital, Sydney, NSW, Australia
⁸Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁹BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹⁰The Medical College of Wisconsin, Brookfield, WI
¹¹Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
¹²Aichi Medical University School of Medicine, Nagakute-cho, Aichi, JPN
¹³Keio University School of Medicine, Tokyo, JPN
¹⁴Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Aichi, Japan
¹⁵Division of Hematology and Clinical Laboratory Medicine, Tottori University Hospital, Yonago, Japan
¹⁶Aichi Medical University, Nagakute, AIC, JPN
¹⁷Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
¹⁸Hospital Sultanah Aminah, Johor Bahru, Malaysia
¹⁹Hospital Ampang, Ampang, Malaysia
²⁰Penang General Hospital, Penang, Malaysia
²¹Hospital Pulau Pinang, Pulau Pinang, Malaysia
²²Children Cancer Hospital Egypt - 57357, Cairo, Egypt
²³American University of Beirut Dept. of Medicine, Beirut, Lebanon
²⁴Pathwel center of Hematology and BMT, Rawalpindi, PAK
²⁵Princess Margaret Hospital, Toronto, ON, CAN
²⁶EHU, Oran, Algeria
²⁷Pierre and Marie Curie Center, Algiers, Algeria
²⁸Hospital Central Del Instituto De Prevision Social, Asuncion, Paraguay
²⁹Hematology, Hospital de Clinicas, Montevideo, Uruguay
³⁰Bone marrow transplant unit, British Hospital, Montevideo, Montevideo, Uruguay
³¹Intensive Hematology Unit, Hospital Del Salvador, Santiago, Chile
³²McMaster University, Hamilton, ON, Canada
³³The Ottawa Hospital, Ottawa, ON, Canada
³⁴Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, CHN
³⁵Peking University People's Hospital, Beijing, China
³⁶Leipzig University, Leipzig, DEU
³⁷St George's University Hospitals, London, United Kingdom
³⁸Sheffield Blood & Marrow Transplant and Cellular Therapy Programme, Sheffield, United Kingdom
³⁹Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany
⁴⁰Department of Haematology, University College London Hospitals NHS Trust, London, ENG, United Kingdom
⁴¹Department of Haematology, Trinity College Dublin, St. James’s Hospital, Dublin, Ireland
⁴²Hospital Universitario de la Princesa, Madrid, Spain
⁴³Unit of Hematology and Stem Cell Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
⁴⁴Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy
⁴⁵Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
⁴⁶Hematology Department, Institut Català d’Oncologia - Hospitalet, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Spain
⁴⁷Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
⁴⁸Division of Hematology, Medical University of Graz, Graz, Austria
⁴⁹Department of Hematology, Stem Cell Transplantation, and Cellular Therapy, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
⁵⁰The Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
⁵¹Universitaetsklinikum Leipzig Aor, Leipzig, Germany
⁵²Hematology, Pitie-Salpetriere Hospital, Greater Paris University Hospitals (AP-HP), Paris, France

Hua Xue^1*, Jianmei Xu^1*, Jing Wang^1*, Songying Zhao^1*, Huimei Guo^1*, Jiangbo Zhang^1*, Jia Liu^1* and Yao Liu²

¹Affiliated Hospital of Hebei University, Baoding, China
²Chongqing University Cancer Hospital, Chongqing, China

Sikander Ailawadhi¹, Sarah M. Larson, MD², Shannon Ferrante^3*, Nicole Rafalko^4,5*, Niodita Gupta-Werner^5*, Jennifer S. Harper, PhD^3*, Rohan Medhekar^5*, Marjohn Armoon, PharmD^6*, Annelore Cortoos, MD^7*, Shuchita Kaila⁵ and Shebli Atrash, MD, MS⁸

¹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
²UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA
³Janssen Scientific Affairs, LLC, Titusville, NJ
⁴Department of Epidemiology and Biostatistics, Drexel University Dornsife School of Public Health, Philadelphia, PA
⁵Janssen Scientific Affairs, LLC, Horsham, PA
⁶Medical Director, Multiple Myeloma, Hematology US Medical Affairs, Johnson & Johnson, Horsham, PA
⁷Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA
⁸Levine Cancer Institute, Charlotte, NC

James A Davis, PharmD^1*, Jordan Snyder, PharmD^2*, Mikhaila Rice, PharmD^3*, Donald C Moore, PharmD, BCPS, BCOP, DPLA, FCCP^4*, Christopher Cahoon, PharmD^5*, Kelley Julian, PharmD^6*, Charlotte B Wagner, PharmD^7*, Katelynn Granger, PharmD^8*, Kimberly M Green, DO^1*, Shebli Atrash, MD⁹, Hailey Hill, PharmD^9*, Jessica McElwee, PharmD^9*, Grace Elsey, PharmD^9*, Jack Khouri, MD¹⁰, Joslyn Rudoni, PharmD^3*, Zahra Mahmoudjafari, PharmD^11* and Victoria Nachar, PharmD^12*

¹Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
³Department of Pharmacy, Cleveland Clinic, Cleveland, OH
⁴Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁵Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
⁶University of Utah Huntsman Cancer Institute, Salt Lake City, UT
⁷Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
⁸Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁹Levine Cancer Institute, Charlotte, NC
¹⁰Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹²Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI

Oya Gilbert^1*, Jack Aiello^2*, Jim Omel^3*, Pamela Price^4*, Audrey Davis^5*, Laura Ortiz-Ravick^6*, Emily Gentry^7*, Richa Shah^8*, Elpitha Soussou^8* and Brandon Blue⁹

¹Patient author, Studio City, CA
²In memoriam, Patient author, Southwest Oncology Group, San Jose, CA
³Patient author, Grand Island, NE
⁴Balm in Gilead, Richmond, VA
⁵Cancer Support Community, Washington, DC
⁶The Leukemia & Lymphoma Society, Rye Brook, NY
⁷Sarah Cannon at HCA Healthcare, Nashville, TN
⁸Pfizer Inc, New York City, NY
⁹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Jaime Miller, MD^1*, Mark Walker, PhD^2*, Dmytro Assonov, MD, PhD^3*, Leena Chhun, BS, BA^1*, Kati O'Brien, BA^1* and C. Anthony Blau, MD¹

¹All4Cure, Seattle, WA
²Walker Research Consulting, Germantown, TN
³Dmytro Assonov Consulting, Kyiv, Ukraine

Betty Gration, BMBCh, MRCP, BSc, M.Bioch^1*, Cameron Wellard, BSc (Hons), PhD^2*, Elizabeth Moore, PhD, MPH, PgradDip (Nurs Crit Care)^2*, Marianne Tan, MBChB³, Matthew Murphy^4*, Kenneth J C Lim, MBBS⁵, James Rowland^6*, Nada Hamad, MBBS, MSc, BSc¹, Rajeev Rajagopal, MD, MBBS^3*, Peter Mollee, FRACP, MBBS, MSc, FRCPA⁷, Andrew Spencer, MBBS, DM (Lond), FRACP, FRCPA^8,9*, Hang Quach, MD, FRACP, FRCPA, MBBS¹⁰ and Georgia McCaughan, BMedSc MBBS MMed (Clin Epi) FRACP FRCPA^1*

¹Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
²School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia
³Middlemore Hospital, Auckland, NZL
⁴Haematology, The Alfred Hospital, Melbourne, Australia
⁵Hematology, St Vincent's Hospital Melbourne, Brunswick, Australia
⁶Princess Alexandra Hospital, Brisbane, AUS
⁷Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
⁸Department of Malignant Haematology, Transplantation and Cellular Therapy Services, Alfred Health, Melbourne, Australia
⁹Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
¹⁰St. Vincent's Hospital Melbourne, East Melbourne, Australia

Arshi Syal, MD^1,2, Yajur Arya, MD^1,2, Bruce Adrian Casipit, MD^1,2*, Claudia Dourado, MD^1,2 and John Charles Leighton, MD^1,2*

¹Albert Einstein Medical Center, Philadelphia, PA
²Thomas Jefferson University Hospital, Philadelphia, PA

Victoria Badia, MD^1*, Apoorva Doshi, MBBS^2*, Gayathri Ravi, MD¹, Susan Bal, MD¹, Kelly Godby^1*, Donna Murdaugh, PhD^2*, Luciano J. Costa, MD, PhD³, Grant Williams, MD^1*, Smita Bhatia, MD, MPH² and Smith Giri, MD, MHS^1*

¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
²Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
³Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL

Markus Rückert^1*, Guillaume Azarias^1*, Mamta Garg, MD^2*, Ceri Bygrave, MBBCh MRCP FRCPath^3*, Hannah Belcher, BN^3*, Clare Hague^4*, Kristina Bardenheuer^5*, Wout Vekemans^6*, Morten Salomo^7*, Blanca Gros Otero^8*, Nolen Perualila^6*, Michel Van Speybroeck^6*, Joris Diels^6*, Vladimir Maisnar, MD, PhD^9*, Ivan Špička^10* and Roman Hájek¹¹

¹TriNetX Oncology GmbH, Freiburg, Germany
²University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
³Cardiff and Vale University, Cardiff, Wales, United Kingdom
⁴Janssen-Cilag GmbH, Neuss, Germany
⁵Oncology Access Solutions Ltd, Macclesfield, United Kingdom
⁶Janssen Pharmaceutica NV, Beerse, Belgium
⁷Janssen-Cilag, Birkerod, Denmark
⁸Janssen-Cilag, Madrid, Spain
⁹Charles University Hospital, Hradec Králové, Czech Republic
¹⁰Charles University Hospital, Prague, Czech Republic
¹¹University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic

Andrew Kowalski, PharmD^1*, David G. Coffey, MD², Benjamin Diamond, MD², James E. Hoffman², Marcella Kaddoura, MD³, Jill Lykon, PharmD^2*, Francesco Maura, MD⁴, Yahirini Rodriguez-Martinez, APRN^2*, Suzan Rosen, APRN^2*, Faika Shah, APRN^2*, Dennis Verducci, APRN^2*, Ola Landgren⁵ and Dickran Kazandjian, MD²

¹Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
²Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
³Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Dearborn, MI
⁴University of Miami, Coral Gables, FL
⁵Sylvester Comprehensive Cancer Center, Miami, FL

Daniel Thomas Jones, OMS-IV^1*, Hazem Aboaid, MD², Ramaditya Srinivasmurthy, OMS-IV^1*, Kevin Nguyen, OMS-IV^1*, Rishi Kumar Nanda, OMS-III^1*, Kyaw Zin Thein, MD³ and Thura Win Htut, MBBS, MRCP, FRCPath^4*

¹Touro University Nevada College of Osteopathic Medicine, Las Vegas
²Department of Internal Medicine, Kirk Kerkorian School of Medicine at University of Nevada, Las Vegas, Las Vegas, NV
³Division of hematology and medical oncology, Comprehensive Cancer Centers of Nevada, Central Valley, Las Vegas, NV
⁴Department of Haematology, Aberdeen Royal Infimary, Aberdeen, United Kingdom

Amy E. Pierre, MSN^1*, Gene Ho, MPH^2*, Olive Mbah, PhD, MHS^3*, Jingru Wang, BA^3* and Cleo A. Ryals, PhD^3*

¹Flatiron Health, River Vale, NJ
²Flatiron Health, San Francisco, CA
³Flatiron Health, New York, NY

Rahul Banerjee, MD, FACP¹, Ruibin Wang, PhD^2*, Yi-Hsuan Liu, PhD, MS, RD^2*, Jinghua He^2*, Hoa H. Le, PhD^2*, Saurabh N. Patel, MD^2* and Xinke Zhang, PhD^2*

¹Fred Hutchinson Cancer Center, Seattle, WA
²Johnson & Johnson Innovative Medicine, Horsham, PA

William A. Wood, MD, MPH¹, Emily A. Semmel, MS^2*, Shandra James^2*, Donna S. Neuberg, ScD³, Kathleen Hewitt, DNP, RN^4*, Kenneth C. Anderson, MD⁵, Shaji Kumar, MD⁶, Mark A. Schroeder, MD⁷, David J. Chung, MD, PhD⁸, Aaron S. Rosenberg, MD⁹, Jeffrey A. Zonder, MD ¹⁰, Samuel M. Rubinstein, MD¹¹, Anita D'Souza, MD¹², Thomas Martin, MD¹³, Ajai Chari, MD¹⁴, Ravi Vij, MD, MBA⁷, Ajay K. Nooka, MD, MPH¹⁵, Brendan M. Weiss, MD¹⁶, Levi D. Pederson, MS^17*, Andriy Derkach, PhD^18*, Susan M. Geyer, PhD¹⁹ and Saad Z. Usmani, MD²⁰

¹Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
²ASH Research Collaborative, Washington, DC
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴ASH Research Collaborative, Gainesville, VA
⁵Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁸Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹UC Davis Comprehensive Cancer Center, Sacramento, CA
¹⁰Karmanos Cancer Institute, Detroit, MI
¹¹Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC
¹²Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹³Department of Hematology, University of California at San Francisco, San Francisco, CA
¹⁴University of California, San Francisco, San Francisco, CA
¹⁵Winship Cancer Institute of Emory University, Atlanta
¹⁶Moderna, Inc., Cambridge, MA
¹⁷Mayo Clinic, Rochester, MN
¹⁸Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁹Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
²⁰Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Farheen Chunara^1*, Mansi R. Shah, MD², Nishi Shah, MBBS, MPH³, Jessica Kent^1*, Ghulam Rehman Mohyuddin, MD⁴, Sabarinath V Radhakrishnan, MD^1*, Gurbakhash Kaur, MD, MA⁵, Rajshekhar Chakraborty, MD⁶, Leo Rasche, MD^7*, Carolina Schinke, MD⁸, Anita D'Souza, MD, MS^9*, Aniko Szabo, PhD^9* and Meera Mohan, MD¹⁰

¹Medical college of Wisconsin, Milwaukee, WI
²Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
³Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
⁶Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
⁷Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany
⁸Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁹Medical College of Wisconsin, Milwaukee, WI
¹⁰Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Lucio Gordan^1*, Amanda Warner^1*, Hannah Granger, BSN^1*, Amy Ming^2*, Cindy Chen^3*, Nicole Rafalko^4,5*, Jennifer S. Harper, PhD^3*, Niodita Gupta-Werner^5*, Rohan Medhekar^5*, Shuchita Kaila⁵, Annelore Cortoos, MD^5* and Trevor Heritage^1*

¹Florida Cancer Specialists & Research Institute, Tampa, FL
²Florida Cancer Specialists & Research Institute, T, FL
³Janssen Scientific Affairs, LLC, Titusville, NJ
⁴Drexel University, Philadelphia, PA
⁵Janssen Scientific Affairs, LLC, Horsham, PA

Apoorva Doshi, MBBS^1*, Abigail Tucker, MSPH^2*, Clare Ubarsax, BS^3*, Gayathri Ravi, MD⁴, Grant Williams, MD^4* and Smith Giri, MD, MHS^4*

¹Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
²University of Alabama at Birmingham, Birmingham, AL
³University of Colorado School of Medicine, Aurora, CO
⁴Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Renee Cheng, MD¹, Ariana Feuvrier-Rivera^2*, Philip Yeung^1*, Anupama Deepa Kumar, MD³ and Ayad Hamdan^4*

¹UCSD Moores Cancer Center, San Diego, CA
²University of California at San Diego Health, San Diego, CA
³University of California, San Francisco, San Francisco, CA
⁴UCSD Moores Cancer Center, La Jolla, CA

Timothy C. Beer, MD^1*, Gloria HJ Graf, PhD^2*, Dee Lin^3*, Mariana Fernandez, MD^4*, Margaret Doyle⁵, Laura L. Hester, PhD, MSc^6*, Bingcao Wu^3* and Stephen Huo, PhD, MD, MsPH^2*

¹Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, PA
²Janssen Global Services, LLC, Raritan, NJ
³Janssen Scientific Affairs, LLC, Horsham, PA
⁴Janssen Cilag S.A., Madrid, Spain
⁵Janssen Global Services, Dublin, Ireland
⁶Janssen Research & Development, LLC, Raritan, NJ

Yonatan Lean, BSc^1*, Andrew Yoon^2*, Kristi Graves, PhD^3*, Betina Yanez, PhD^1*, Christine Rini, PhD^4* and Jonathan Moreira, MD⁴

¹Northwestern University Feinberg School of Medicine, Chicago, IL
²Northwestern University Feinberg School of Medicine, Hawthorn Woods, IL
³Georgetown University School of Medicine, Washington, DC
⁴Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Binoy Yohannan, MD^1,2, Matthew James Rees, MD¹, Morie A. Gertz, MD¹, Angela Dispenzieri, MD¹, Francis Buadi, MD¹, David Dingli, MD, PhD¹, Nelson Leung, MD³, Prashant Kapoor, MD⁴, Wilson I. Gonsalves, MD¹, Taxiarchis Kourelis, MD¹, Joselle Cook, MBBS¹, Moritz Binder, MD¹, Martha Lacy, MD^1*, Suzanne R Hayman, MD¹, Yi Lin, MD, PhD¹, Yi Lisa Hwa, APRN, DNP, CNP¹, Michelle G Rogers^1*, Miriam Hobbs, APRN, CNP, DNP^1*, Amie Fonder, PA-C, MS^1*, Ronald S Go, M.D.¹, Rahma M Warsame, MD¹, Vincent Rajkumar, MD^1*, Shaji Kumar, MD¹ and Eli Muchtar, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
³Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN

Luciano J. Costa, MD, PhD¹, Thomas W. LeBlanc, MD, MA, MS², Hans Tesch^3*, Pieter Sonneveld, MD⁴, Sarasa M.A. Johnson^5*, Francis Vekeman^5*, Patrick Hlavacek^6*, Aster Meche^6*, Paul Cislo^7*, David Hughes, PharmD⁸, Guido Nador^9* and Marco DiBonaventura^6*

¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL
²Duke Cancer Institute, Hillsborough, NC
³Bethanien Hospital, Frankfurt, Germany
⁴Erasmus MC Cancer Institute, Rotterdam, Zuid-Holland, Netherlands
⁵Statlog, Montreal, Canada
⁶Pfizer Inc, New York, NY
⁷Pfizer Inc, Groton, CT
⁸Pfizer, Cambridge, MA
⁹Pfizer Ltd, Surrey, United Kingdom

Bhavesh Mohan Lal, MD¹, Alan Baltz, MD^2*, Mamatha Gaddam, MD², Ankur Varma, MD², Cesar Giancarlo Gentille Sanchez, MD² and Muthu V. Kumaran, MD^2*

¹University of Arkansas for Medical Sciences, Little Rock, Little Rock, AR
²University of Arkansas for Medical Sciences, Little Rock, AR

Blin Nicolas^1*, Christine Mai, MD^2*, Siegfried Ertl, MBA^3*, Elodie Schneider, MBA^2*, Marine Leberre, MBA^2*, Melissa Yilmaz, MSc^2* and Alexandre Raffy^4*

¹Hematology, Nantes University Hospital, Nantes, FRA
²AplusA, Lyon, France
³AplusA, London, United Kingdom
⁴APLUSA, Lyon, France

Darryl Chang, MD^1,2, Alma Habib, MD^2,3, Andrew Vegel, MD^2,4*, Emily Struble, DNP^2,4*, Hira Shaikh, MD^2,4, Christopher Strouse, MD^2,4, Kimberly M Green, DO^2,5*, Muhammad Umair Mushtaq^2,6, Zahra Mahmoudjafari, PharmD^2,6*, Hamza Sloan Hashmi, MD^7,8*, Joseph P. McGuirk, DO^2,9, Abdullah Mohammad Khan, MD, MBBS^2,3, Al-Ola Abdallah, MD^2,9, Nausheen Ahmed, MD^2,6, Shebli Atrash, MD, MS^1,2 and Manisha Bhutani, MD^1,2

¹Levine Cancer Institute, Atrium Health, Charlotte, NC
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Division of Hematology, The Ohio State University, Columbus, OH
⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁵Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁶Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁷Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
⁸US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS

Bhavesh Mohan Lal, MD¹, Toshali Pandey^2*, Marah Alzubi^3*, Jawad Alrawabdeh^3*, John D Shaughnessy, Jr, PhD^4*, Fenghuang Zhan, MD⁵, Eric Siegel^6*, Carolina Schinke, MD⁵, Sharmilan Thanendrarajan, MD⁷, Maurizio Zangari, MD⁵, Frits van Rhee, MD, PhD⁵ and Samer Al Hadidi, MD, MSc⁷

¹University of Arkansas for Medical Sciences, Little Rock, Little Rock, AR
²University of Arkansas for Medical Sciences, Little Rock
³University of Jordan, Amman, Jordan
⁴Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical sciences, Little Rock, AR
⁵Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁶Department of Biostatistics, University of Arkansas For Medical Sciences, Little Rock, AR
⁷University of Arkansas for Medical Sciences, Little Rock, AR

Alvaro Alvarez Soto, MD¹, Junmin Song, MD², Jackson Clark, DO³, Katharine Hooper, FNP-BC^1*, Maxine Amber Braun^4*, Princy Shah, MD^4* and Swarup Kumar, MBBS¹

¹Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut, Farmington, CT
²Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY
³University of Connecticut, Farmington
⁴University of Connecticut, Farmington, CT

Poorva Bindal, MD¹, Marcela Banegas^2*, Rodrigo Paredes^3*, Maria Jose Hernandez Woodbine^4*, Pushan Aggarwal^5*, Jon E. Arnason, MD⁶ and Carolyn D Alonso, MD^7*

¹Division of Hematology/Oncology, Department of Medicine, UMass Chan Medical School, Grafton, MA
²Johns Hopkins Bloomberg School of Public Health, Baltimore
³Icahn School of Medicine at Mount Sinai Hospital, New York City, NY
⁴Norwalk Hospital/Yale University, Norwalk
⁵Allegheny Health, Pittsburg
⁶Beth Israel Deaconess Medical Center, Boston, MA
⁷Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Behzad Amoozgar, MD, MPH¹, Ayrton I Bangolo, MBBS², David H. Vesole, MD, PhD^3,4, David S. Siegel, MD, PhD⁵, Noa Biran, MD³, Pooja Phull, MD^3*, Michele L. Donato, MD⁶ and Harsh Parmar, MD³

¹John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
²John Theurer Cancer Center at Hackensack University Medical Center, Edgewater, NJ
³Division of Multiple Myeloma, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
⁴Lombardi Comprehensive Cancer Center, Medstar Georgetown Medical Center, Washington, DC, DC
⁵Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health and Center for Discovery and Innovation, Hackensack, NJ
⁶Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ

Michael Daunov, DO¹, Benjamin Gorham, PhD^2* and James J Ignatz-Hoover, MD, PhD³

¹Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
²Freedman Center for Digital Scholarship, Kelvin Smith Library, Case Western Reserve University, Cleveland, OH
³Case Comprehensive Cancer Center, Cleveland Heights, OH

Lisa Herms, PhD^*, Zhaohui Su, PhD^*, Jessica Paulus, ScD^* and Ira Zackon, MD

Ontada, Boston, MA

Xuezhu Xu^1*, Rui Liu^2*, Ruoyu Yang^3*, Wanhong Zhao, PhD, MD^4*, Baiyan Wang, MD, PhD^4*, Fangxia Wang^3* and Aili He, PhD, MD^5*

¹Department of Hematology, Xi'an Jiaotong University Second Affiliated Hospital,Xi'an Key Laboratory of Hematological Diseases, XI'AN, China
²Department of hematology, Xi'an Jiaotong University Second Affiliated Hospital,Xi'an Key Laboratory of Hematological Diseases, Xi'an, China
³Department of Hematology, Xi'an Jiaotong University Second Affiliated Hospital,Xi'an Key Laboratory of Hematological Diseases, Xi'an, China
⁴Department of Hematology, The Second Affiliated Hospital of Xi’an Jiao Tong University, Xi'an Key Laboratory of Hematological Diseases, Xi'an, China
⁵Department of Hematology, The Second Affiliated Hospital of Xi’an Jiao Tong University, Xi'an Key Laboratory of Hematological Diseases, Xi’an, China

Ishita Kamboj^1,2*, Darryl Chang, MD³, Alma Habib, MD⁴, Andrew Vegel, MD^5*, Emily Struble, DNP^5*, Hira Shaikh, MD^2,5*, Christopher Strouse, MD^2,5, James A Davis, PharmD^2,6*, Aliya Rashid, DO, MPH^2,7,8, Kevin Graf, MD^2,9*, Kimberly M Green, DO^10*, Muhammad Umair Mushtaq, MD^2,8, Zahra Mahmoudjafari, PharmD^2,8*, Hamza Sloan Hashmi, MD^11,12,13*, Joseph P. McGuirk, DO⁸, Al-Ola Abdallah, MD^2,8, Shebli Atrash, MD^2,14, Abdullah Mohammad Khan, MD, MBBS^2,4 and Nausheen Ahmed, MD^2,15

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, KANSAS CITY, MO
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁴Division of Hematology, The Ohio State University, Columbus, OH
⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁶Department of Hematology-Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁷Internal Medicine, University of Kansas Medical Center, Kansas City, KS
⁸Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁹Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
¹⁰Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
¹¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
¹²Department of Hematology-Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, NY
¹³US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
¹⁴Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
¹⁵University of Kansas Cancer Center, Kansas City, KS

Phyu Thin Naing, MD¹, Divya Chukklore, MD^2*, Jessica Jung, BS^3*, Clary Evans, MD, MA, MSc^4* and Jessica Caro, MD⁵

¹Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, NY
²Zuckerberg Cancer Center, Northwell Health Cancer Institute, New Hyde Park, NY
³Northwell Health Cancer Institute, New Hyde Park, NY
⁴Radiation Oncology Department, Northwell Health Cancer Institute, New Hyde Park, NY
⁵Zuckerberg Cancer Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY

Rusha Bhandari, MD, MS¹, Qingrui Meng, MS^2*, Nora Balas, PhD^3*, Alysia Bosworth, BA^4*, F. Lennie Wong, PhD¹, Wendy Landier, PhD^2*, Liton Francisco^5*, Elizabeth Ross^3*, Ravi Bhatia, MD⁶, Smita Bhatia, MD, MPH³, Saro Armenian, DO, MPH⁴ and Lindsey Hageman, MPH^5*

¹City of Hope, Duarte, CA
²University of Alabama At Birmingham, Birmingham, AL
³University of Alabama at Birmingham, Birmingham, AL
⁴City of Hope National Medical Center, Duarte, CA
⁵Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁶Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL

Mahmoud R. Gaballa, MD¹, Thomas G. Martin, MD², Nobuhiro Tsukada, MD, PhD³, Kazuhito Suzuki, MD, PhD⁴, Hirono Iriuchishima, MD, PhD^5*, Emilie Chalayer, MD, PhD^6*, Vincent Camus, MD, PhD^7*, Maria Magdalena Alcala Peña^8*, Anna Furlan, MD^9*, Max Christian Georg Hubmann^10*, Wolfgang Ulrich Knauf, MD^11*, Christina Tekle^12*, Ani Minasyan^12*, Chunfu Qiu^13* and Meral Beksac^14,15*

¹Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematology, University of California at San Francisco, San Francisco, CA
³Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
⁴Division of Clinical Oncology/ Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⁵Department of Hematology, National Hospital Organization Shibukawa Medical Center, Gunma, Japan
⁶Department of Hematology, Centre Hospitalo Universitaire de Saint-Etienne, Saint Etienne, France
⁷Department of Hematology, Centre Henri Becquerel, Rouen, France
⁸Department of Hematology, Hospital Universitario Carlos Haya, Malaga, Spain
⁹Divisione di Ematologia, Ospedale Cà Foncello di Treviso-ASL 2, Treviso, Italy
¹⁰Praxis für Hämatologie und Onkologie, Herrsching, Germany
¹¹Centrum für Hämatologie und Onkologie Bethanien, Frankfurt, Germany
¹²Sanofi, Cambridge, MA
¹³Sanofi, Cambridge
¹⁴Istinye University Ankara Liv Hospital, Ankara, Turkey
¹⁵Department of Hematology, Ankara University, Ankara, Turkey

Yoshiaki Marumo, MD^1*, Masaki Ri, MD, PhD^2,3*, Toru Ebina, MD^4*, Tomoyuki Nakamura^1*, Hirokazu Sasaki, MD^2*, Shiori Kinoshita, MD, PhD^2*, Tomoko Narita, MD, PhD^2*, Tomotaka Suzuki^2*, Takaomi Sanda, MD, PhD², Takanori Nanri^3*, Hirokazu Komatsu, MD, PhD^2* and Shinsuke Iida, MD, PhD⁵

¹Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, AIC, Japan
²Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
³Department of Blood Transfusion and Cell Therapy, Nagoya City University Hospital, Nagoya, Japan
⁴Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Aomori, Japan
⁵Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan

Jordan Snyder, PharmD^1,2*, Kevin Graf, MD^1,3*, James A Davis, PharmD^1,4*, Marshall McKenna, MD^1,5*, Yun Kyoung Tiger, MD, PhD^1,5, Mehak M Laharwal, MD^1,6, Prerna Mewawalla, MD^1,7*, Omar Alkharabsheh, MD^1,8*, Hamza Sloan Hashmi, MD^9,10*, Hira Shaikh, MD^1,11*, Jonathan Lochner, PharmD^11*, Darryl Chang, MD^1,12, Shebli Atrash, MD, MS^1,12, Alma Habib, MD^1,13, Priyanka Venkatesh, MBBS^1,14, Zahra Mahmoudjafari, PharmD^1,15*, Nausheen Ahmed, MD^1,16, Muhammad Umair Mushtaq, MD^1,2, Al-Ola Abdallah, MD^1,15, Kimberly M Green, DO^1,4* and Abdullah Mohammad Khan, MD, MBBS^1,13

¹US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
³Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁴Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁵Division of Hematology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁶Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pitts, PA
⁷Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
⁸University of South Alabama, Mobile, AL
⁹Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
¹⁰US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
¹¹Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
¹²Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
¹³Division of Hematology, The Ohio State University, Columbus, OH
¹⁴Internal Medicine, The University of Kansas Medical Center, Kansas City, KS
¹⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁶University of Kansas Cancer Center, Kansas City, KS